Sox6 has been implicated in diabetic nephropathy (Jiang et al., 2020; Qi et al., 2019), adipogenesis (Leow et al., 2016), cardiomyopathy (Yousefzadeh et al., 2017), inflammatory bowel disease (Kinchen et al., 2018), and cancer (Liang et al., 2019). This evidence concerns the gene SOX6 and diabetic kidney disease.